عنوان
پدید آورنده
موضوع
رده
RC271.B53 B55 2000
RC271
.
B53
B55
2000
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
0781722721
NATIONAL BIBLIOGRAPHY NUMBER
Number
dltt
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Biologic therapy of cancer /
General Material Designation
[Book]
First Statement of Responsibility
edited by Steven A. Rosenberg
EDITION STATEMENT
Edition Statement
3rd ed
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Philadelphia, PA :
Name of Publisher, Distributor, etc.
Lippincott Williams & Wilkins,
Date of Publication, Distribution, etc.
2000
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xvii, 916 p. :
Other Physical Details
ill. ;
Dimensions
29 cm
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
Ch. 1. Interleukins: overview -- Ch. 2. Interleukin-2: precinical trials -- Ch. 3. Interleukin-2: clinical applications -- Ch. 4. Interleukin-4: clinical applications -- Ch. 5. Interleukins-12: clinical applications -- Ch. 6. Colony-stimulating factor: basic principles and preclinical studies -- Ch. 7. Colony-stimulating factors: clinical applications -- Ch. 8. Tumor necrosis factors: basic principles and clinical applications in systemic and regional cancer treatment -- Ch. 9. Interferon- and -: clinical applications -- Ch. 11. Interferon-: basic principles and clinical applications -- Ch. 12. Cell transfer therapy: basic principles and preclinical studies -- Ch. 13. Cell transfer therapy: clinical applications -- Ch. 14. Monoclonal antibodies: basic principles -- Ch. 15. Monoclonal antibodies: clinical applications -- Ch. 16. Cancer vaccines: cancer antigens -- Ch. 17. Cancer vaccines: basic principles -- Ch. 18. Cancer vaccines: clinical applications -- Ch. 19. Basic principles of gene therapy -- Ch. 20. Gene therapy: clinical applications -- Ch. 21. Antiangiogenesis: basic principles -- Ch. 22. Antiangiogenesis: clicical applications -- Ch. 23. Delivery of biologic molecules and cells to tumors -- Ch. 24. Flt-3 and flt-3 ligand -- Ch. 25. CTLA-4 blockade in tumor immunotherapy
0
TOPICAL NAME USED AS SUBJECT
Biological response modifiers-- Therapeutic use
Cancer-- Gene therapy
Cancer-- Immunotherapy
Immunologic Factors-- immunology
Immunologic Factors-- therapeutic use
Immunotherapy
Neoplasms-- therapy
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC271
.
B53
Book number
B55
2000
OTHER CLASS NUMBERS
Class number
QZ
266
Book Number
B6145
2000
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Rosenberg, Steven A
ORIGINATING SOURCE
Date of Transaction
20000915151714.0
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
